Salicylate-induced enzymuria: comparison with other anti-inflammatory agents.
N-acetyl-beta glucosaminidase (NAG) enzymuria was used as a marker of renal injury in patients with rheumatic disease. An elevated NAG level was particularly common in patients receiving gold or aspirin therapy. The multiplicity of drugs received and the unknown role of underlying disease in these patients led to a study in healthy volunteers. Customary therapeutic doses of aspirin, choline salicylate, ibuprofen, indomethacin and acetaminophen did not produce enzymuria. Large single doses of salicylates equivalent to 6 tablets of aspirin consistently did produce enzymuria. The size of the individual dose in relation to body weight was more important than the total daily dose. NAG enzymuria appears to be a sensitive tool for identifying potentially nephrotoxic drugs.
D000082:Acetaminophen / Q000009:adverse effects; D000118:Acetylglucosaminidase / Q000652:urine*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D006046:Gold / Q000008:administration & dosage / Q000009:adverse effects; D006596:Hexosaminidases / Q000652:urine*; D006801:Humans; D007052:Ibuprofen / Q000009:adverse effects; D007213:Indomethacin / Q000009:adverse effects; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000201:enzymology; D008247:Lysosomes / Q000201:enzymology; D012216:Rheumatic Diseases / Q000188:drug therapy; D012459:Salicylates / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D012459:Salicylates; D000082:Acetaminophen; D006046:Gold; D006596:Hexosaminidases; D000118:Acetylglucosaminidase; D001241:Aspirin; D007052:Ibuprofen; D007213:Indomethacin